Insider Transactions Reported by 21 Insiders of X4 Pharmaceuticals, Inc

Symbol
XFOR on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

X4 Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paula Ragan President and CEO, Director $1,515,173 -$34,719 -2.2% 12 Feb 2025
John Volpone President $1,136,333 29 Oct 2025
Adam R. Craig Executive Chairman, Director $1,090,652 +$249,997 +30% 29 Oct 2025
David Kirske Chief Financial Officer $757,555 29 Oct 2025
Mary DiBiase Chief Operating Officer $518,005 -$10,094 -1.9% 12 Feb 2025
Christophe Arbet-Engels Chief Medical Officer $392,350 -$5,284 -1.3% 12 Feb 2025
Adam S. Mostafa Chief Financial Officer $385,900 -$33,947 -8.1% 12 Feb 2025
Arthur Taveras Chief Scientific Officer $218,459 04 Oct 2024
Derek Meisner Chief Legal Officer $130,640 17 Aug 2022
Diego Cadavid Chief Medical Officer $93,696 01 Mar 2022
Alison Frances Lawton Director $85,241 10 Jun 2024
William Aliski Director $85,241 10 Jun 2024
Mark Baldry Chief Commercial Officer $62,886 -$13,241 -17% 16 May 2025
Rene Russo Director $7,680 02 Jun 2021
Natasha Fay Thoren Chief Legal Officer $1,797 20 May 2025
Murray Stewart Director $1,497 01 Jan 2026
Keith Woods Director $1,140 09 Jun 2025
MICHAEL S. WYZGA Director $1,055 01 Jan 2026
Gary Bridger Director $897 01 Jan 2026
DAVID W. J. MCGIRR Director $897 09 Jun 2025
Francoise de Craecker Director $897 01 Jan 2026

Recent Insider Transactions by Companies or Individuals for X4 Pharmaceuticals, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.